False Claims Act litigation

Novartis and Novartis Pharmaceuticals Corporation

Our attorneys have obtained a dismissal with prejudice on behalf of Novartis Pharmaceuticals Corporation and Novartis Corporation of a qui tam suit brought in the United States District Court for the District of Massachusetts.  The suit, which was brought by multiple relators under the False Claims Act, alleged off label and kickback claims in connection with the asthma drug, Xolair®.

Email Disclaimer